Biotech innovator Liquidia, specializing in pulmonary therapies, reported a notable insider sale amid continued growth in its ...

Wearable device data may help detect and track idiopathic pulmonary arterial hypertension, a rare lung disease, a study ...

Allrock Bio has dosed the first participants in a small clinical trial testing ROC-101 as an add-on treatment for pulmonary ...

Cautionary Language Concerning Forward-Looking Statements ...

WILMINGTON, DE — Inhibikase Therapeutics Inc. (Nasdaq: IKT) has enrolled the first patient in its Phase 3 clinical trial ...

A wireless implantable device that remotely monitors pulmonary artery pressure offers reliable safety and is linked to a significant reduction in the risk for heart failure-related hospitalisation.

CM uniquely uses hands-on instruction to facilitate knowledge transfer, offering a unique opportunity for patients with ...

Scottish Medicines Consortium approves new NHS Scotland drugs for lung cancer, leukaemia, cervical cancer, pulmonary ...

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.